What does european hospital liability — year 10 mean?

This metric captures the financial performance of the European hospital liability insurance segment in the tenth year of the reporting cycle. It reflects the cumulative impact of underwriting strategies and market conditions on the company's European healthcare liability business. This long-term view is critical for assessing the durability of the company's competitive advantage and its ability to manage complex medical liability risks over a decade.

King Pharmaceuticals KG European Hospital Liability — Year 10

Other product segments

General Liability

3.4%—

Commercial Auto Liability

0.9%—

International

-0.8%—

All other lines

-0.1%—

Similar metrics at other companies

CNAMedical Professional Liability — Year 10

0.4%-1.2pp

ORIGeneral Liability — Year 10

2.5%+0.7pp

GLREHealth — Year 10

0%—

AIGUK/Europe Casualty and Financial lines — Year 10 (as a percent)

3.2%+1.6pp

AXSInsurance — Year 10

3.5%—

CNAOther Professional Liability and Management Liability — Year 10

0.7%+0.1pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's european hospital liability — year 10.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's european hospital liability — year 10?: King Pharmaceuticals (KG) reported european hospital liability — year 10 of 4.9% in Q4 2025.
What does european hospital liability — year 10 mean?: This metric captures the financial performance of the European hospital liability insurance segment in the tenth year of the reporting cycle. It reflects the cumulative impact of underwriting strategies and market conditions on the company's European healthcare liability business. This long-term view is critical for assessing the durability of the company's competitive advantage and its ability to manage complex medical liability risks over a decade.